Research, Development and Production to Support Clinical Trials for HIV Vaccines

支持 HIV 疫苗临床试验的研究、开发和生产

• 批准号: 9368890
• 负责人: DAVID LINDSAY
• 金额: $ 530万
• 依托单位: LEIDOS BIOMEDICAL RESEARCH, INC.
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-09-16 至 2021-09-15
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9368890
• 关键词: Clinical; Clinical Research; Clinical Trials; Communicable Diseases; Development; Disease Outbreaks; HIV; HIV vaccine; Mission; National Institute of Allergy and Infectious Disease; Preclinical Testing; Production; Services; Testing; clinical material; preclinical study; programs; research and development; research clinical testing; vaccine candidate

The NIAID mission and scope includes rapidly responding to infectious disease outbreaks through research, development and clinical testing of HIV vaccines. The VRC seeks to facilitate development of HIV vaccine products leading to protection against HIV. The objectives is to develop and manufacture clinical materials, and carry out preclinical and non-clinical testing of HIV vaccines required for advancement of products to clinical studies.

NIAID的使命和范围包括通过艾滋病毒疫苗的研究、开发和临床试验对传染病的爆发作出迅速反应。VRC寻求促进艾滋病毒疫苗产品的开发，从而保护免受艾滋病毒感染。 其目标是开发和生产临床材料，并对HIV疫苗进行临床前和非临床试验，以便将产品推向临床研究。